Related Experiment Video
Updated: Apr 21, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
miR-31 promotes proliferation of colon cancer cells by targeting E2F2
Tong Li1, Wenjing Luo, Kunmei Liu
1School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People's Republic of China, litong198824@163.com.
Abstract:
MicroRNA-31 (miR-31) plays important roles in colon cancer development. However, the underlying mechanism is still not clear. We have explored the functions of miR-31 on proliferation of colon cancer cells as well as the underlying mechanism. E2F2 was identified as a direct target of miR-31. miR-31 regulated the proliferation of colon cancer cells by targeting E2F2. Moreover, in the present study, E2F2 acted as a tumor suppressor in colon cancer by repressing the expression of survivin and regulating the expression of CCNA2, C-MYC, MCM4 and CDK2. A possible mechanism for the function of miR-31 on colon cancer proliferation is presented and indicates that miR-31 might become a target for anti-cancer drug design.
Insights
MicroRNA-31 (miR-31) promotes colon cancer growth by targeting E2F2. E2F2 suppresses tumors by regulating key cell cycle genes, offering a potential target for colon cancer drug design.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-31 (miR-31) is implicated in colon cancer progression.
- The precise molecular mechanisms driving miR-31's role in colon cancer remain incompletely understood.
Purpose of the Study:
- To investigate the functional role of miR-31 in colon cancer cell proliferation.
- To elucidate the underlying molecular mechanism of miR-31 action in colon cancer.
Main Methods:
- Identification of direct miR-31 targets using molecular biology techniques.
- Assessment of miR-31's impact on colon cancer cell proliferation.
- Analysis of E2F2's tumor suppressor functions and its regulation of downstream genes.
Main Results:
- E2F2 was confirmed as a direct molecular target of miR-31.
- miR-31 was shown to regulate colon cancer cell proliferation through its interaction with E2F2.
- E2F2 demonstrated tumor suppressor activity by inhibiting survivin expression and modulating CCNA2, C-MYC, MCM4, and CDK2.
Conclusions:
- miR-31 promotes colon cancer cell proliferation by targeting the tumor suppressor E2F2.
- E2F2's regulation of cell cycle genes highlights its critical role in colon cancer.
- These findings suggest that miR-31 represents a potential therapeutic target for colon cancer treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

